Never miss a thing

Keep up to date on the latest news and industry opinions on the biosimilar topics that matter to patients, providers, and payers.

Latest articles

New EMA biosimilar guidelines for healthcare professionals

Healthcare professionals in the EU and US still have a cautious approach towards using biosimilars in clinical practice because of concerns …

Read more

Europe and FDA guidance on biosimilar interchangeability

The number of approvals for biosimilar products is steadily increasing in Europe, the USA and other regions to combat the economic burden of…

Read more

Understanding the rules on biosimilar reimbursement policy

Biosimilars are defined by the European Medicines Agency as high-quality biological drugs that are highly similar to and show no clinically …

Read more

Tearing down the barriers to accessing biosimilars

Many European states have adopted strategies to balance their national budgets with special focus on healthcare, because of the financial an…

Read more

Can biosimilars drive value beyond just price?

A look at the interests of various stakeholders and how biopharmaceutical companies are taking on the challenge of biosimilars reveals a com…

Read more

What every patient needs to know about biosimilars

A quick guide to biosimilar medicines, how they’re made, and why you can trust them to be safe and effective.

Read more